Cargando…

Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer

Sarcopenia, the degenerative and systemic loss of skeletal muscle mass, indicates patient frailty and impaired physical function. Sarcopenia can be caused by multiple factors, including advanced age, lack of exercise, poor nutritional status, inflammatory diseases, endocrine diseases, and malignanci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukushima, Hiroshi, Takemura, Kosuke, Suzuki, Hiroaki, Koga, Fumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213561/ https://www.ncbi.nlm.nih.gov/pubmed/30275370 http://dx.doi.org/10.3390/ijms19102999

Ejemplares similares

Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
por: Koga, Fumitaka, et al.
Publicado: (2018)

Impact of sarcopenia in bladder preservation therapy for muscle-invasive bladder cancer patients: a narrative review
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2015)

Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma
por: Une, Minami, et al.
Publicado: (2022)

A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer
por: Takemura, Kosuke, et al.
Publicado: (2021)

Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2019)

Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy
por: Fukushima, Hiroshi, et al.
Publicado: (2016)

Novel anatomical apical dissection utilizing puboprostatic “open-collar” technique: Impact on apical surgical margin and early continence recovery
por: Koga, Fumitaka, et al.
Publicado: (2021)

Impact of Serum γ-Glutamyltransferase on Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel
por: Une, Minami, et al.
Publicado: (2021)

A Case of Renal Pelvic Cancer Complicated by Horseshoe Kidney Treated with RoboSurgeon Gasless Single-Port Retroperitoneoscopic Nephroureterectomy
por: Suzuki, Hiroaki, et al.
Publicado: (2018)

Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
por: Koga, Fumitaka
Publicado: (2020)

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives
por: Ohishi, Tomokazu, et al.
Publicado: (2015)

A Case of Metastatic Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome-Associated Renal Cell Carcinoma Treated with a Sequence of Axitinib and Nivolumab Following Cytoreductive Nephrectomy
por: Yonese, Ichiro, et al.
Publicado: (2020)

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy
por: Ohtaka, Ayako, et al.
Publicado: (2019)

Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach
por: Nishi, Hiroshi, et al.
Publicado: (2020)

Nutritional and Nutrition-Related Biomarkers as Prognostic Factors of Sarcopenia, and Their Role in Disease Progression
por: Papadopoulou, Sousana K., et al.
Publicado: (2022)

Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia
por: Takemura, Koji, et al.
Publicado: (2020)

Artificial‐intelligence‐driven discovery of prognostic biomarker for sarcopenia
por: Chung, Heewon, et al.
Publicado: (2021)

Prognostic Impact of Sarcopenia in Patients with Advanced Prostate Carcinoma: A Systematic Review
por: de Pablos-Rodríguez, Pedro, et al.
Publicado: (2022)

Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer
por: Chin, Fee-Wai, et al.
Publicado: (2023)

Impact of Sarcopenia on Spinal Spondylosis: A Literature Review
por: Kitsuda, Yuki, et al.
Publicado: (2023)

The sex‐specific prognostic utility of sarcopenia in cirrhosis
por: Lowe, Ryan, et al.
Publicado: (2022)

Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
por: Lee, Ji Hyun, et al.
Publicado: (2021)

Prognostic Impact of Sarcopenia’s Occurrence during Radiotherapy in Oropharyngeal Cancer Patients
por: Bergamaschi, Luca, et al.
Publicado: (2023)

Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2019)

The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis
por: Fang, Pinhao, et al.
Publicado: (2022)

Renal Angiomyolipoma Mimicking a Well-Differentiated Retroperitoneal Liposarcoma
por: Fuse, Honoka, et al.
Publicado: (2020)

Clinical Impact of Sarcopenia on Cholangiocarcinoma
por: Shin, Suk-Pyo, et al.
Publicado: (2022)

Plasma Transthyretin as A Biomarker of Sarcopenia in Elderly Subjects
por: Ingenbleek, Yves
Publicado: (2019)

Circulating Biomarkers in Bladder Cancer
por: Nandagopal, Lakshminarayanan, et al.
Publicado: (2016)

The impact of sarcopenia on the postoperative outcome in colorectal cancer surgery
por: Benedek, Zalán, et al.
Publicado: (2023)

Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer
por: Pathak, Ram Anil, et al.
Publicado: (2018)

The contemporary role and impact of urine-based biomarkers in bladder cancer
por: Duquesne, Igor, et al.
Publicado: (2017)

Rehabilitation Nutrition and Exercise Therapy for Sarcopenia
por: Kakehi, Shingo, et al.
Publicado: (2022)

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
por: Quan, Jing, et al.
Publicado: (2018)

Sarcopenia’s Prognostic Impact on Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Lee, Donggun, et al.
Publicado: (2021)

Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?
por: Picca, Anna, et al.
Publicado: (2020)

Impact of sarcopenia on the prognosis and treatment of lung cancer: an umbrella review
por: Lin, Ting-Yu, et al.
Publicado: (2022)

Plasma acylcarnitine in elderly Taiwanese: as biomarkers of possible sarcopenia and sarcopenia
por: Lo, Chi-Jen, et al.
Publicado: (2023)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
por: Yoon, Han Gyul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hjg3ggcqlkaqi36petpi8p023v